Novartis AG (NVS)
103.64
+0.55
(+0.53%)
USD |
NYSE |
Nov 21, 15:09
Novartis Price: 103.64 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 102.80 | 103.19 | 102.46 | 103.09 | 1.049M |
| Nov 19, 2024 | 102.58 | 103.35 | 102.40 | 103.27 | 1.237M |
| Nov 18, 2024 | 102.48 | 103.42 | 102.41 | 103.04 | 1.002M |
| Nov 15, 2024 | 102.92 | 103.30 | 102.59 | 103.06 | 1.452M |
| Nov 14, 2024 | 104.13 | 104.68 | 103.37 | 103.40 | 1.637M |
| Nov 13, 2024 | 104.03 | 104.16 | 103.38 | 103.86 | 1.826M |
| Nov 12, 2024 | 105.16 | 105.23 | 104.41 | 104.92 | 1.094M |
| Nov 11, 2024 | 106.22 | 106.40 | 105.48 | 105.67 | 1.081M |
| Nov 08, 2024 | 106.61 | 106.69 | 106.13 | 106.45 | 1.177M |
| Nov 07, 2024 | 106.57 | 107.10 | 106.17 | 107.08 | 1.293M |
| Nov 06, 2024 | 107.81 | 107.83 | 106.44 | 106.81 | 1.370M |
| Nov 05, 2024 | 108.97 | 109.45 | 108.57 | 109.38 | 745178.0 |
| Nov 04, 2024 | 110.90 | 111.23 | 110.26 | 110.52 | 1.055M |
| Nov 01, 2024 | 109.86 | 110.02 | 109.30 | 109.35 | 1.112M |
| Oct 31, 2024 | 108.46 | 108.83 | 107.94 | 108.40 | 1.404M |
| Oct 30, 2024 | 110.63 | 110.99 | 109.73 | 109.91 | 2.846M |
| Oct 29, 2024 | 111.81 | 112.77 | 109.81 | 110.53 | 3.155M |
| Oct 28, 2024 | 114.28 | 115.76 | 114.16 | 115.63 | 1.603M |
| Oct 25, 2024 | 113.65 | 114.09 | 113.50 | 113.79 | 904084.0 |
| Oct 24, 2024 | 114.08 | 114.24 | 113.12 | 113.13 | 622027.0 |
| Oct 23, 2024 | 113.98 | 114.27 | 113.75 | 114.07 | 1.158M |
| Oct 22, 2024 | 114.16 | 114.54 | 113.93 | 114.32 | 858955.0 |
| Oct 21, 2024 | 116.77 | 116.85 | 115.59 | 115.73 | 646524.0 |
| Oct 18, 2024 | 116.62 | 117.36 | 116.29 | 117.18 | 655649.0 |
| Oct 17, 2024 | 116.51 | 116.72 | 116.08 | 116.51 | 975389.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
66.87
Minimum
Mar 23 2020
120.89
Maximum
Aug 30 2024
88.72
Average
85.69
Median
Jan 12 2023
Price Benchmarks
| AstraZeneca PLC | 63.86 |
| Johnson & Johnson | 156.03 |
| Eli Lilly and Co | 752.47 |
| Novo Nordisk AS | 103.12 |
| Monte Rosa Therapeutics Inc | 8.53 |
Price Related Metrics
| PE Ratio | 12.15 |
| PS Ratio | 4.256 |
| PEG Ratio | 0.0940 |
| Price to Book Value | 4.783 |
| Price to Free Cash Flow | 16.99 |
| Earnings Yield | 8.23% |
| Market Cap | 207.20B |
| PEGY Ratio | 0.0914 |
| Operating PE Ratio | 15.63 |
| Normalized PE Ratio | 18.06 |